Work

Antidepressant Class and Concurrent rTMS Outcomes in MDD: a Systematic Review and Meta-Analysis

Year: 2025
Type: review
Abstract: Repetitive transcranial magnetic stimulation (rTMS) is increasingly used alongside antidepressants for managing major depressive disorder (MDD). This systematic review and meta-analysis aimed to evaluate the clinical efficacy and safety of specific antidepressant classes when combined with rTMS. A comprehensive search of major databases identified 14 randomized controlled trials (RCTs) with an experimental arm of medication with adjunctive rTMS and a control arm of medication and sham rTMS. Trials focused on selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs), including 848 participants (mean age: SSRIs 41.1 years, SNRIs 51.8 years). rTMS combined with SSRIs significantly improved depression scores (SMD = −0.65, p = 0.0002), response rates (OR = 0.97, p < 0.0001), and remission rates (OR = 1.04, p < 0.0001). In contrast, no significant benefit was observed with SNRIs. Overall, these results suggest that not all antidepressant combination therapies are alike, and SSRIs should be considered when initiating rTMS.
Author: Zaidi, Alina
Language: English
Subfield: Neurology
Open Access status: green
OpenAlex ID: W7132862816
FWCI:
Cites: 406
Cited by:
Related to: 9